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Abstract
Background: Aging in animals is associated with high body oxidative stress, which might affect
susceptibility and onset of age-related diseases, and the subsequent life span. Therefore, genes that
modulate oxidative stress might play a role in determining longevity. In this study, we investigated
whether the gene pool relevant to the SOD2-9T/C and MTHFR 677C/T polymorphisms changes as
the Jordanian population ages.
Methods: Polymorphisms were genotyped in 130 elderly subjects (57 females and 73 males, mean
age: 90.01 years) and 135 young control subjects (67 females and 68 males, mean age: 33.43 years).
Results: No significant differences were found in the genotype and allele frequencies of examined
SOD2 and MTHFR gene variants between the elderly group and young controls (P > 0.05), nor when
each gender was considered separately (P > 0.05).
Conclusion: SOD2-9T/C and MTHFR 677C/T gene polymorphisms do not seem to be important
in Jordanian population for longevity phenotype.
Background
Aging involves increases in oxidative stress status pre-
sented by elevated levels of oxidized forms of biomole-
cules in the body of the organism [1]. This leads to tissue
damage and decreases in body functions, homeostasis,
and tolerance to chronic diseases [2,3]. Thus, genes that
modulate oxidative stress might play a role in human lon-
gevity.
In this study, we investigated association of SOD2 -9T/C
SNP and MTHFR 677 C/T SNP with longevity in Jorda-
nian population. The SOD2 gene codes for the mitochon-
drial manganese superoxide dismutase, a major cellular
antioxidative stress enzyme [4]. SOD2 dismutates the
superoxide anion into hydrogen peroxide that is detoxi-
fied into water by glutathione peroxidases and catalase
[5]. Presence of the C allele at -9 position of SOD2 gene
results in substitution of alanine for valine (Ala16Val) in
the mitochondrial targeting sequence [6]. This substitu-
tion partially retains SOD2 enzyme within the narrow
inner membrane import pore and lowers the enzyme
activity [7,8]. The importance of SOD2 -9T/C polymor-
phism is indicated by its association with several age
related diseases such as cancer [9,10] and diabetic neph-
ropathy [11].
The  MTHFR  gene codes for methylenetetrahydrofolate
reductase that catalyzes the conversion of 5,10-methyl-
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enetetrahydrofolate to 5-methyltetrahydrofolate. The lat-
ter serves as a methyl donor in the reaction converting
homocysteine to methionine [12]. The T allele at 677
position of MTHFR gene causes substitution of alanine to
valine and the resulting decreases in enzyme activity and
increases in body homocysteine concentrations [13].
Excess homocysteine undergoes auto-oxidation in
plasma, so that free oxygen radicals are produced thereby
enhancing endothelial tissue damage and inflammation
[14]. In addition, excess homocysteine can directly impair
DNA methylation, resulting in altered gene expression
[15]. The MTHFR  677 C/T polymorphism has been
shown to be associated with ischemic stroke [16], cancer
[17] and coronary artery disease [18].
Previous reports are variable on the association between
SOD2 -9 SNP or MTHFR 677 SNP with human longevity.
For example, positive association has been reported
between SOD2 -9 SNP and Ashkenazi males [19], but not
Italian population [20]. Similarly, positive association has
been reported between MTHFR SNP, and Swiss popula-
tion or Ashkenazi women [19,21], but not Irish popula-
tion [22]. In this study, we report absence of association
between -9 T/C SOD2 SNP or 677 C/T MTHFR SNP with
longevity in the examined sample of Jordanian elderly.
Methods
One hundred thirty unrelated elderly subjects (> 85 years,
mean age 90.01 year) volunteered from different parts of
Jordan to take part in this study. Another 135 unrelated
young control subjects (range from 20 to 50 years, mean
age 33.34 years) were matched long-lived individuals for
geographical origin. Subjects with cardiovascular diseases,
diabetes, or cognitive impairments were excluded from
the study. The experimental design and the sample size
were similar to most longevity studies reviewed by Glatt et
al., [23]. Subject's mean ages were selected based on the
mortality rate in the Jordanian population, which is
approximately constant from childhood to late forties,
thereafter, it starts gradually inclining to reach maximum
in late seventies [24]. Therefore, individuals who reach
more than 85 years are rare in Jordan. An official identifi-
cation document was required to participate in the study.
Acceptable documents include civil ID card, birth certifi-
cate, family book, passport and military card, otherwise
enrolment in the study was denied. All subjects received
written and verbal explanation of the study before giving
consent. The study protocol was approved by the Institu-
tional Review Boards of Jordan University of Science and
Technology.
Blood samples (1-3 ml) in EDTA tubes were obtained
from all subjects. DNA was extracted from all samples
using Wizard DNA Extraction Kit (Promega, Madison,
USA) according to the manufacturer instructions. DNA
samples were stored at -20°C until used. The concentra-
tion of the extracted DNA was measured using Smart-
Spect™ 3000 (Bio-Rad, Hertfordshire, UK).
SOD2  T-9C polymorphism was typed using RFLP-PCR
protocol. Briefly, 20 μl reaction mixture containing 5 ng
of template DNA, 0.75 unit GoTaq polymerase (Promega,
Madison, USA), and a final concentration of 200 mM
each deoxynucleotide and 1× reaction buffer, and 1 mM
of forward (5'-ACC AGC AGG CAG CTG GCG CCG G-3')
and reverse (5'-GCG TTG ATG TGA GGT TCC AG-3')
primers. Cycling was performed at 95°C for 15 min and
35 cycles at 94°C for 30 s, 65°C for 30 s and 72°C for 30
s, followed by a final extension of 7 min at 72°C. PCR
products were detected using electrophoresis on 4% agar-
ose, confirming the presence of a 107 bp product. The
NgoMIV enzyme (Fermentas. GmbH, St. Leon-Rot, Ger-
many) digestion was carried out in 20 ul reaction mixture
containing 3 units of enzyme and 10 μl of PCR product at
37°C for 4 hours. Materials from individuals
homozygous for SOD2 -9 T allele don't cut with NgoMIV
and remain as a 107 bp product. The homozygous SOD2
-9 C allele cuts with NgoMIV to give 89 bp and 18 bp frag-
ments.
The MTHFR C677T polymorphism was also analyzed by
PCR-RFLP using Hinf I enzyme (Fermentas). PCR primers
were: forward primer (5'-TGA AGG AGA AGG TGT CTG
CGG GA-3') and reverse primer (5'-AGG ACG GTG CGG
TGA GAG TG-3'). Polymerase chain reaction and Hinf I
digestion condition were similar to that described for
SOD2 -9 SNP except for the annealing temperature, which
was 60°C in this case. PCR fragments from MTHFR 677 C
allele don't cut with Hinf I and remain as a 198 bp product
while fragments from MTHFR 677 T allele cut with Hinf I
to give 175 bp and 23 bp fragments.
The genotype distributions of the examined polymor-
phisms were analyzed in agreement with Hardy-Weinberg
equilibrium. To test association between longevity and
the polymorphic loci, distributions of allele and genotype
frequencies were compared between young and elderly
groups using the chi-square and Fisher's exact tests. The
test power was calculated for alleles frequency using
Power and Sample Size Calculation Program (PS version
3.0.1, Vanderbilt University Medical Center, Nashville,
TN, USA) and for genotype frequencies using SAS macro
[25]. For all analysis, the power was more than 75%. The
SPSS 15.0 statistical software package (SPSS Inc., Chicago,
IL) was used for statistical analysis. P values smaller than
0.05 were considered significant.
Results
Jordan is a small country located in Southwest Asia and
classified among the low income countries. The popula-BMC Geriatrics 2009, 9:57 http://www.biomedcentral.com/1471-2318/9/57
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tion is predominantly Arab (98%) and most of it is urban
(70%) [26]. According to the 2007 census, the total pop-
ulation of Jordan was 5.7 million, percentage of individu-
als of 65 years of age or older was 4.1% and life expectancy
at birth in the total population was 73 year [26].
The average age of the elderly group in the study was
90.01 years. In Jordan, the mortality rate starts inclining
exponentially at fifty year-old getting maximum level in
the late seventies indicating that reaching above 85 year-
old is a rarity (Khoury et al., 1999). Therefore, oldest old
people (> 85 year-old) are considered exceptional individ-
uals in Jordan.
Males to females ratio was 1.3:1 in the elderly group and
1:1 in the control group (P = 0.346). Number of relatives
who exceeded 85 year-old was higher in the elderly group
compared to the young control group (70.3% versus
59.8%, respectively, P = 0.013). The higher number of rel-
atives who exceeded 85 year-old (>25%) in the elderly
group indicates the presence of genetic component to lon-
gevity in the Jordanian population.
Table 1 shows the frequency of homozygous and hetero-
zygous genotypes for SOD2  T-9C and MTHFR  C677T
SNPs in our sample of elderly and young controls. The
genotype frequencies of the SOD2 T-9C SNP of elderly
and control groups were not statistically different (Chi
square test, P = 0.576). Accordingly, the frequency of SNP
-9 T to C was not significantly different between elderly
and controls (Chi square test, P = 0.355). Similar results
were observed with the MTHFR C677T SNP (Chi square
test: for genotype frequencies, P = 0.944 and for allele fre-
quencies, P = 0.727).
Several studies indicated that gender was a main variable
in the genetics of longevity and suggested that men and
women might follow different pathways to reach longev-
ity [27,28]. In our sample, genotypes and alleles frequen-
cies for examined SNPs were not different when males
were considered alone (Chi square test: for -9 T/C SOD2,
P = 0.691 and for 677 C/T MTHFR, P = 0.795, Table 2), or
when females were considered alone (Chi square test: for
-9 T/C SOD2, P = 0.317 and for 677 C/T MTHFR, P =
0.792, Table 3).
Discussion
Oxidative stress is a condition where the redox balance
between oxidant and antioxidant is shifted toward an oxi-
dized state. In animals, oxidative stress increase with age-
ing due to high production of free radicals by aged
mitochondria and decreased cellular antioxidant capacity.
The mitochondrial magnesium superoxide dismutase
(SOD2) is considered the first line of defense against reac-
tive oxygen species [4]. The gene for SOD2 has a common
T to C polymorphism, resulting in a valine to alanine
change at the 16 position of its mitochondrial targeting
sequence (Ala16Val), which affects the structure of the
protein [6], and reduces its entrance into the mitochon-
dria [29] leading to increased oxidative stress.
The  MTHFR  gene also affects oxidative stress status in
human body. The gene codes for an enzyme that play a
key role in the folate metabolism [30]. Nucleotide transi-
tion (C to T) at nucleotide 677 of MTHFR causes alanine
to valine substitution in the N-terminal catalytic domain,
leading to 30% and 65% reduction in activity for hetero-
zygotes and homozygotes of the variant allele, respec-
tively [31]. Reduced activity of MTHFR leads to high levels
of blood homocysteine, which is rapidly auto-oxidized,
leading to the production of cytotoxic reactive oxygen spe-
cies and to endothelial damage [32].
Table 1: Frequencies of SOD2 and MTHFR alleles and genotypes in elderly and control groups.
Genotypes and Alleles Control group
N (percentage)
Elderly group
N (percentage)
P value
-9 SOD2 *
TT 42 (31.1) 44 (33.8)
TC 61 (45.2) 62 (47.7)
CC 32 (23.7) 24 (18.5) 0.576
Allele T 145 (53.7) 150 (57.7)
Allele C 125 (46.3) 110 (42.3) 0.355
677 MTHFR *
CC 82 (60.7) 77 (59.2)
CT 41 (30.4) 40 (30.8)
TT 12 (8.9) 13 (10.0) 0.944
Allele C 205 (75.9) 194 (74.6)
Allele T 65 (24.1) 66 (25.4) 0.727
* All groups were in Hardy Weinberg equilibrium (P > 0.05).BMC Geriatrics 2009, 9:57 http://www.biomedcentral.com/1471-2318/9/57
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In this study, we hypothesized that the presence of the C
allele at -9 position of SOD2 and T allele at position 677
of MTHFR might decrease life span. The data showed no
statistically significant difference between the elderly and
young groups when comparing genotypic distributions
and allelic frequencies of studied SOD2 and MTHFR pol-
ymorphisms (Table 1). In agreement with our results, De
Benedictis et al., [20] showed that SOD2 variant does not
affect individual life expectancy in Italian population
(sample size: 109, age criterion > 100 years old). In addi-
tion, Brattstrom et al., [22] reported that MTHFR C677T
allele is not a strong risk factor for premature death in Ire-
land (sample size: 1388, age criterion > 80 years old). In
animal models, mice deficient in SOD2 (Sod2-/-) exhibit
neonatal lethality in association with dilated cardiomyop-
athy and a massive lipid accumulation in the liver [33],
while (Sod2+/-) heterozygous mice have increased cancer
incidence without affecting aging [34]. Furthermore, SOD
isoforms showed no effect on life span in C. elegans [35]
and Drosophila [36]. In contrast to our results, positive
association has been reported in Danish population (sam-
ple size: 1650, age criterion > 92 years old) [37] and
Ashkenazi males (sample size 150, > 75 years old [19]
with SOD2 -9 SNP, while for MTHFR, positive association
has been reported in Swiss population (sample size: 104,
age criterion > 65 years old) and Ashkenazi women (sam-
ple size: 74, age criterion > 75 years old) [19,21]. The dis-
crepancy in the finding of the different studies might be
due to difference in experimental design, sample size and
criteria used in selecting subjects. In addition, the exam-
ined polymorphisms/longevity associations might have a
population specific component, being affected by the
population specific gene pool as well as by gene-environ-
ment interaction.
Among the limitations of this study are the sample size
and age of recruitments of elderly subjects (≥ 85 years).
One hundred and thirty subjects with a mean age of 90.01
years were included in the present study. The population
of Jordan was 5.7 million in 2007 and only 4.1% of the
total population was individuals of 65 years of age or
older [26]. In addition, the mortality rate starts inclining
exponentially at fifty year-old getting maximum level in
the late seventies indicating that reaching above 85 year-
Table 2: Frequencies of SOD2 and MTHFR alleles and genotypes in elderly and control male subjects
Genotypes and Alleles Control males group
N (percentage)
Elderly males group
N (percentage)
P value
-9 SOD2
TT 17 (25) 23 (31.5)
TC 35 (51.5) 34 (46.6)
CC 16 (23.5) 16 (21.9) 0. 691
Allele T 69 (50.7) 80 (54.8)
Allele C 67 (49.3) 66 (45.2) 0.495
677 MTHFR
CC 42 (61.8) 41 (56.2)
CT 21 (30.9) 26 (35.6)
TT 5 (7.4) 6 (8.2) 0.795
Allele C 105 (77.2) 108 (74.0)
Allele T 31 (22.8) 38 (26.0) 0.528
Table 3: Frequencies of SOD2 and MTHFR alleles and genotypes in elderly and control female subjects
Genotypes and Alleles Control Females group
N (percentage)
Elderly Females group
N (percentage)
P value
-9 SOD2
TT 25 (37.3) 21 (36.8)
TC 26 (38.8) 28 (49.1)
CC 16 (23.9) 8 (14.0) 0. 317
Allele T 76 (56.7) 70 (61.4)
Allele C 58 (43.3) 44 (38.6) 0.455
677 MTHFR
CC 40 (59.7) 36 (63.2)
CT 20 (29.9) 14 (24.6)
TT 7 (10.4) 7 (12.3) 0.792
Allele C 100 (74.6) 73 (72.3)
Allele T 34 (25.4) 28 (27.7) 0.686BMC Geriatrics 2009, 9:57 http://www.biomedcentral.com/1471-2318/9/57
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old is a rarity (Khoury et al., 1999). Therefore, oldest old
people are considered exceptional individuals in Jordan.
Moreover, the lack of elderly centers in Jordan makes it
very hard to recruit elderly subjects that fit sampling crite-
ria. Despite all these obstacles, the sample size of the cur-
rent research fall within the range of longevity studies
reviewed by Glatt et al., [23] and previous studies that
asked the same question in other populations (see discus-
sion above). Future studies with a bigger sample size
might be more appropriate with this kind of research.
Longevity is a complex trait, which likely results from a
blessed combination of genetic and non-genetic factors
[38]. It is possible that the excess of environmental factors
exert stronger influence on longevity than the genetic
traits [39]. For example, in institutionalized or home-
bound elderly, oxidative stress was reported to increase
significantly [40,41], while in free living elderly it is not
always elevated [42]. In addition, MTHFR C677T poly-
morphism effect on homocysteine level can be minimized
by folate intake. Studies attempting to assess the overall
genetic influence on variations in the human life span
indicated that approximately a quarter of the variation in
the adult life spans could be attributed to genetic variation
among individuals [43]. Thus, the strong influence of
environmental factors on longevity might wipe the most
likely weaker effect of genetic factors as observed in this
study. However, the result which shows that number of
relatives who exceeded 85 year-old was higher in the eld-
erly group by approximately 25% compared to the young
control group indicates the presence of genetic compo-
nent to longevity in the Jordanian population. It is possi-
ble that other polymorphisms are present in the region of
the examined genes in the Jordanian population; this
might buffer out or modulate the effect of the studied loci.
Therefore, further studies are required to screen for the
presence of such modifier polymorphisms in addition to
direct measurement of levels and activity of gene products
of the examined loci in according to subject's genetic
background.
Reaching extreme age without diseases is one aspect of
successful ageing [23]. In this study, elderly individuals
with cardiovascular diseases, diabetes, or cognitive
impairments were excluded from the current study. Previ-
ous studies have shown that SOD2 -9T/C and MTHFR 677
C/T polymorphisms were associated with diabetes, cancer
and cardiovascular diseases in other populations [9,10].
Thus, these polymorphisms might also associate with cer-
tain diseases in the Jordanian population. Exploring this
possibility is a matter of future research.
Conclusion
In this study, we investigated the contribution of the
SOD2-9T/C and MTHFR 677C/T gene polymorphisms to
the longevity phenotype in the Jordanian population. The
results of this study indicate that SOD -9T/C and MTHFR
677C/T are not important determinant of life span in Jor-
danian population.
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